Research Paper Volume 12, Issue 6 pp 5362—5383

Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway

Figure 10. Cartoon demonstrating that delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.